|
(MoneyNewsWire.Net, March 27, 2018 ) The global fill-finish manufacturing market is projected to reach USD 4.47 Billion by 2022 from USD 2.96 Billion in 2017, at a CAGR of 8.6% during the forecast period. Technological advancements in fill-finish products, growth of the biopharmaceutical industry, rising adoption of prefilled syringes, and increase in fill-finish outsourcing are the major factors driving this market.
Explore More Information about report @ https://www.researchcosmos.com/reports/global-fill-finish-manufacturing-market-analysis-and-forecast-to-2022-growth-opportunity-assessmen/6486917
Based on products, the consumables segment is expected to account for the largest share of the global market. This segment is also expected to register the highest CAGR during the forecast period. The large share and high growth of this segment is primarily attributed to the rising demand for prefilled syringes, growth of the plastic prefilled syringes market, and wide applications of vials in lyophilization.
By end user, the contract manufacturing organizations segment is expected to account for the largest share of the global market in 2017 and is expected to register the highest CAGR during the forecast period. This can primarily be attributed to the rising demand for outsourcing the fill-finish manufacturing process and growing number of new entrants in the biologics manufacturing market.
Request free sample @ https://www.researchcosmos.com/request/6486917
Geographically, the fill-finish manufacturing market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2017, Europe is expected to account for the largest share of the global market. The large share of the European region is mainly attributed to factors such as the emergence of biosimilar market due to patent expiry of key biologic products, rising incidence of chronic disorders, and the increasing focus of major players on increasing their presence in Europe. The APAC region is projected to grow at the highest CAGR during the forecast period. The growth of the global market in this region is driven by the overall growth in the biopharmaceutical industry.
Isolators and RABS are equipped with advanced features and functionalities and are therefore priced at a premium, as compared to standalone systems. This severely restricts their accessibility, especially for small companies. Owing to this, the adoption of isolators and RABS is very low as compared to standalone systems in underdeveloped or developing countries, including China and India. Furthermore, research institutes find it difficult to afford such instruments, as they have restricted budgets for the purchase of such instruments. The use of standalone systems still prevails among these end users.
The key players in this market include Becton, Dickinson and Company (US), West Pharmaceutical Services, Inc. (West Pharmaceutical Services) (US), Gerresheimer AG (Gerresheimer) (Germany), Robert Bosch GmbH (Robert Bosch) (Germany), IMA (Italy), OPTIMA (Germany), and Nipro Medical Corporation (US).
Check for discount @ https://www.researchcosmos.com/discount/6486917
About Us:
Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.
Research Cosmos
Dani Rodriguez
+1 888 709 8757
dani@researchcosmos.com
Source: EmailWire.Com 
|
